A chemotactic inhibitor in synovial fluid

Area of Science:

• Immunology
• Biochemistry
• Rheumatology

Background:

• Neutrophil chemotaxis is vital for inflammatory responses.
• Synovial fluid's role in joint inflammation is complex.
• Existing knowledge on synovial fluid inhibitors of neutrophil function is limited.

Purpose of the Study:

• To identify and characterize an inhibitor of neutrophil chemotaxis in synovial fluid.
• To elucidate the mechanism and properties of this inhibitor.
• To explore its potential role in regulating joint inflammation.

Main Methods:

• Synovial fluid incubation with complement-deactivated serum.
• Chemotaxis assays using zymosan-activated serum and N-formyl-methionyl-leucyl-phenylalanine.
• Enzyme treatments (trypsin, hyaluronidase) and heat inactivation.
• Gel filtration for molecular weight determination.

Main Results:

• A neutrophil chemotaxis inhibitor was detected in synovial fluid after complement deactivation.
• The inhibitor was most effective against C5a-derived chemotaxis, not N-formyl-methionyl-leucyl-phenylalanine.
• Inhibitor activity was abolished by boiling and trypsin treatment, indicating a protein nature.
• Gel filtration estimated the inhibitor's molecular weight at approximately 25,000 Da.

Conclusions:

• Synovial fluid contains a heat-labile, trypsin-sensitive protein inhibitor of neutrophil chemotaxis.
• This inhibitor appears to modulate inflammatory cell recruitment in joints.
• The findings suggest a regulatory mechanism in synovial fluid that influences inflammatory processes.